Track the Canadian Junior Mining Market at the speed of AI

Build a portfolio of Canadian junior mining companies on 6ix and get real-time updates the minute they announce something. Discover investor events, company profiles, and news in one place.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
11m ago	Mountain Valley MD Advances Quicksome™ Sublingual Delivery Platform for Compounded Peptide Applications, Reports on Initial Formulation Work Across Multiple Peptides Including BPC-157 Mountain Valley Md Holdings Inc
11m ago	New TECVAYLI®▼ (teclistamab) data demonstrate superior progression-free and overall survival versus standard of care as early as first relapse in multiple myeloma Johnson & Johnson
12m ago	Moleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limits Moleculin Biotech, Inc.
12m ago	New TECVAYLI® (teclistamab-cqyv) data demonstrate superior progression-free and overall survival as early as first relapse in multiple myeloma Johnson & Johnson
12m ago	MidOcean Partners Signs Definitive Agreement to Sell Zonda to CoStar Group Costar Group, Inc.

About

2.06USD-0.01 -0.48%

Closed • Updated at 12:53 GMT+00:00

Market Cap$357.57M

Volume1.34M

Beta0.19

RSI54.64

Health TechnologyPharmaceuticals: Major

Palisade Bio, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Palisade Bio to Participate in the Jefferies Global Healthcare Conference

Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108

Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis

Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026

Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference

Recent Videos

New Ulcerative Colitis Drug Shows Promising Results in Early Trials

New Ulcerative Colitis Drug Shows Promising Results in Early Trials

May 07, 2026

My 2025 Takeaway from PALISADE BIO's Annual Report

My 2025 Takeaway from PALISADE BIO's Annual Report

Mar 24, 2026

PALI, Palisade Bio, Inc. stock prices historical data

PALI, Palisade Bio, Inc. stock prices historical data

Mar 21, 2026

Palisade Bio, Inc. (PALI) #stock #nasdaq #autoimmune_inflammatory_and_fibrotic_diseases

Palisade Bio, Inc. (PALI) #stock #nasdaq #autoimmune_inflammatory_and_fibrotic_diseases

Feb 21, 2026

Community Chat

Ask AI

Try asking